December
12
  3:07:56 PM

Message from editor: new comments system

BioEdge introduces a new comments systemWe are currently sprucing up the BioEdge website. One of the first innovations is a better system for your comments. We have incorporated "Intense Debate", an add-on which allows you to set up a profile, build up a reputation in the BioEdge community, respond to other comments by email or through your RSS reader, or even post simultaneously on Twitter. One thing that has been missing on BioEdge is a robust debate around the controversial issues that we raise and I am sure that this will catch on. 

At the foot of each article in this newsletter you will find a link which will take you to the article on the website. Below it will open up a panel for your comments. I hope that this will make visiting the site more interesting, even compelling. Of course, we do ask that your comments be reasonably concise, on-topic and polite. Feel free to correct us if you think that we have made an error of fact or of judgement. 

We hope to roll out other improvements over the next few weeks. 

Cheers,
Michael Cook
Editor, BioEdge



 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Neuroscience as the military’s new weapon
9 Feb 2012
Single-embryo transfers? Fugedaboudit, says NY IVF doctor
9 Feb 2012
Dutch celebrate a decade of euthanasia with a film festival
6 Feb 2012
Lost in surrogacy’s Bermuda Triangle
3 Feb 2012
Scores of UK patients die with bedsores, infections and malnutrition
3 Feb 2012

 Tags
India, Canada, HFEA, UK, organ trafficking, organ donation, IVF, suicide, sperm donation, stem cells, research, genetic testing, bioethics, sex selection, US, abortion, China, Netherlands, human drama, euthanasia, informed consent, surrogacy, Down syndrome, Australia, commercialization, clinical trials, neuroscience, embryonic stem cells, assisted suicide, law,